Dr. Alexander N. Slade, MD, PhD

Dr. Slade practices at Stony Brook University Hospital in Stony Brook, New York, part of Stony Brook University.

Dr. Slade's NPI, 1093195281, was assigned on June 3, 2015. Dr. Slade holds Virginia license 0116028957.

Dr. Slade's primary practice is Stony Brook University Hospital, at Health Sciences Center Suny, Stony Brook, NY 11794 in Suffolk County. The practice phone is (631) 444-4000. Dr. Slade also practices at Stony Brook University Hospital, 101 Nicolls Rd, Stony Brook, NY 11794.

Dr. Slade's primary practice is Stony Brook University Hospital in Stony Brook, New York, part of Stony Brook University. The medical group on file is Stony Brook Radiation Oncology. Dmand AI also links Dr. Slade to 1 more clinical lab, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Slade practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Slade's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Slade is licensed in Virginia.

CMS data shows 2,947 Medicare services from Dr. Slade across 17 procedure codes in 2024, for 313 Medicare patients. Medicare paid $200,574 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 313 Medicare patients who saw Dr. Slade in 2024. The largest group is 75 to 84, with 136 patients. 75% of them have cancer, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Slade's median patient age at 72, with 5% women.

In 2024, Dr. Slade wrote 227 Medicare Part D claims for 94 patients. 92% of them were for generic drugs. CMS names the drug for 211 of them, across 5 drugs with 11 or more claims each, at $51,946 in total drug cost. In 2023, CMS named 240 claims across 5 drugs.

Dr. Slade accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. Slade, published from 2018 to 2024. 2019 was the busiest year, with 5. The most frequent topics are Breast Neoplasms, Mastectomy, Segmental and Prostatic Neoplasms. Dr. Slade has published most often in Adv Radiat Oncol. Dr. Slade's most frequent co-authors are Justin Darrell Anderson, MD, Prudvi Raju Arabandi, MD and Emma Charlotte Fields, MD.

Dmand AI links Dr. Slade to 5 clinical trials, 3 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Erectile Dysfunction. NRG Oncology sponsors the most, 3.

CMS Open Payments shows 14 general payments to Dr. Slade from 10 drug and device companies from 2020 to 2025. Honoraria make up the largest share, 57% of the total. C. R. Bard, Inc. & Subsidiaries paid the most, $1,149.